Novel treatment of sleep apnea by upper airway and respiratory muscle training
Project Number5I21RX002885-03
Contact PI/Project LeaderSANKARI, ABDULGHANI
Awardee OrganizationJOHN D DINGELL VA MEDICAL CENTER
Description
Abstract Text
Project Summary Abstract
Title: Novel treatment of sleep apnea by upper airway and respiratory muscle
training.
In recent years, we and others have discovered that spinal cord injury/disease (SCI/D) is
associated with significant increase in the sleep-disordered breathing (SDB) prevalence.
Nearly 80% of patients with SCI/D including Veterans suffer from SDB after six months
of injury (majority of them 70-80% are obstructive apneas and hypopneas-OSA).
However, most patients SCI/D do not tolerate standard SDB treatment (continuous
positive airway pressure-CPAP) leading to lack of compliance. Therefore, identifying
other therapies is important for this common condition that is linked to poor outcome in
the general population (heart disease, stroke, hypertension and poor cognition). It has
been reported in sleep apnea able-bodied patients that oropharyngeal muscle exercises
for 3 months using speech pathology techniques improve the severity of SDB.
Furthermore, previous studies showed respiratory muscle training (RMT) is effective for
increasing respiratory muscle strength in people with cervical SCI. However, the effect of
combined oropharyngeal and RMT on OSA in patients with SCI is unknown.
The purpose of this application is to identify new therapeutic interventions for OSA
treatment in Veterans with SCI/D. This application proposes for a pilot study to
randomizing 30 Veterans with SCI/D and OSA to receive 3 months of daily (30 minutes)
treatment with a validated set of oropharyngeal and RMT (intervention arm) versus sham
therapy (control arm). There will be three specific aims to address the following
hypotheses:
Specific Aim (1): To test recruitment rate and feasibility of a pilot intervention that
includes combined oropharyngeal and RMT versus sham treatment in individuals with
SCI/D.
Specific Aim (2): To test the acceptability and usability of combined oropharyngeal and
RMT in individuals with SCI/D.
Specific Aim (3): To determine the effect size estimates for clinical endpoints and their
associated variability at the end of treatment to calculate an appropriate sample size for
an adequately powered clinical trial.
Public Health Relevance Statement
It is estimated that spinal cord injury (SCI) affects approximately 12,000 new individuals every
year in the United States, with the majority being cervical and/or upper thoracic injuries. Despite
the high prevalence of sleep disordered breathing (SDB) in chronic SCI population, only a
minority of patients are treated and are adherent to standard therapy (CPAP). This proposal
addresses a new therapeutic intervention for sleep apnea in SCI. We hypothesize that
combined oropharyngeal and respiratory muscle exercises improve respiratory symptoms and
alleviate SDB in patients with chronic SCI. We will perform a pilot randomized, sham-controlled
study to examine the impact of combined daily exercises (~30 min) for 1 and 3 month durations
among Veterans with SCI. We believe this novel approach to treating SDB will yield significant
new knowledge that improves the health and quality of life of these patients.
No Sub Projects information available for 5I21RX002885-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5I21RX002885-03
Patents
No Patents information available for 5I21RX002885-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5I21RX002885-03
Clinical Studies
No Clinical Studies information available for 5I21RX002885-03
News and More
Related News Releases
No news release information available for 5I21RX002885-03
History
No Historical information available for 5I21RX002885-03
Similar Projects
No Similar Projects information available for 5I21RX002885-03